voice searchcamera search
Everolimus

Everolimus

Get Latest Price

Brand Name :

Everolimus

In Stock

In Stock

Product Specifications

Dosage5mg
FormTablets
PackagingBlister Pack
Quantity30 tablets
StorageRoom temperature
ExpirySee packaging
CompositionEverolimus
FeaturesTargeted Therapy, Cancer Treatment, mTOR Inhibition, Improved Outcomes, Convenient Dosage, Reduced Side Effects

Company Details

Since our commencement in 2016, we, Isum Pharma are acting as a responsible pharmaceutical products trader and exporter. Our offerings include Bortenat Injection, Calutide Tablet, Alimta Injection, Alphalan Tablet, Altraz Tablet etc. We assure our clients, that these products are procured by our diligent team of agents who only choose certified vendors. We are a part of an industry which has relations with the health and well-being of people owing to which we are careful at each step while serving our customers. The products we offer have become the first preference of many major hospitals, nursing homes, dispensaries etc all across the India and in many foreign nations. In a short period of time, our company's name has earned great recognition due to our dedication and eagerness to reach the summit of industry. Cu

Business Type

Exporter, Manufacturer, Distributor, Supplier, Trading Company

Employee Count

20

Establishment

2016

Working Days

Monday To Sunday

GST NO

24CEUPB6905B1ZQ

Related Products

More Products From This Seller

Seller Details

GST

GST - 24CEUPB6905B1ZQ

4 RatingRating

Surat, Gujarat

Seller Inquiry

Accepts only Foreign inquiries

Proprietor

Mr Mayur

Address

Shop No. 406, Sunshine Complex, Sudama Chowk, Mota Varachha, Surat, Gujarat, 394101, India

everolimus in Surat

Report incorrect details

Compare With Similar Products

Buyer Feedback

4

4

Price Or Price Range

500 INR (Approx.)

4000 INR (Approx.)

Minimum Order Quantity

1 Unit/Units

10 Strip/Strips

Dosage Form

Tablets

doctorconsultants

Indication

Used in treatment of cancer (breast, pancreatic, lung, kidney), organ rejection in transplant patients, advanced hormone receptor-positive, HER2-negative breast cancer and advanced renal cell carcinoma

Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system.

Feature

Other, Oral administration, targeted therapy, immunosuppressive and anti-cancer properties

Dry Enzyme

Ingredients

Other , Everolimus and excipients

100% Yeast

Application

Other, Pharmaceutical/Medical

Food Additives

Fermentation Smell

Other, Odorless

Normal Smell

Shelf Life

24 months

2 Years